Eli Lilly stock also has a Composite Rating of 82, a measure of fundamental and technical metrics. Follow Reinhardt Krause on Twitter @reinhardtk_tech for updates on artificial intelligence, ...

an actor with Max Reinhardt’s troupe, really was a vampire. Director Robert Eggers, actor Emma Corrin, director of photography Jarin Blaschke and actors Lily-Rose Depp and Aaron Taylor-Johnson ...

Lili Reinhart is opening up about her health, revealing that she’s spent the last year dealing with an unknown chronic ...

BLOOMINGTON — Mya Edwards was too ill to play Thursday in the semifinals of the McLean County/Heart of Illinois Conference ...

In “Lilly,” writer-director Rachel Feldman follows the era-defining work of one such everyday woman: trailblazer Lilly Ledbetter, a pioneer from humble beginnings who took her employer ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market.

Eli Lilly has been riding the weight-loss drug wave. The company's weight-loss drugs have been shown to be more effective than rival Ozempic. The stock currently trades at an attractive valuation.

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...